×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TARS – tarsus pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TARS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/18
06:57 am
tars
Tarsus Pharmaceuticals (TARS) was upgraded by Lifesci Capital to "strong-buy".
Medium
Report
Tarsus Pharmaceuticals (TARS) was upgraded by Lifesci Capital to "strong-buy".
3/11
02:47 pm
tars
Tarsus Pharmaceuticals, Inc. (TARS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Tarsus Pharmaceuticals, Inc. (TARS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/9
12:27 am
tars
Assessing Tarsus Pharmaceuticals (TARS) Valuation After Recent Mixed Share Performance [Yahoo! Finance]
Low
Report
Assessing Tarsus Pharmaceuticals (TARS) Valuation After Recent Mixed Share Performance [Yahoo! Finance]
3/6
10:36 am
tars
Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating [Yahoo! Finance]
Low
Report
Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating [Yahoo! Finance]
2/28
01:30 am
tars
Tarsus Pharmaceuticals (TARS) was downgraded by Wall Street Zen from
Low
Report
Tarsus Pharmaceuticals (TARS) was downgraded by Wall Street Zen from
2/27
06:26 am
tars
Tarsus Pharmaceuticals (TARS) was downgraded by Zacks Research from "strong-buy" to "hold".
Low
Report
Tarsus Pharmaceuticals (TARS) was downgraded by Zacks Research from "strong-buy" to "hold".
2/26
04:30 pm
tars
Tarsus to Participate in Upcoming Investor Conferences
Low
Report
Tarsus to Participate in Upcoming Investor Conferences
2/26
12:42 am
tars
Has The Market Rerated Tarsus Pharmaceuticals (TARS) Too Cautiously After XDEMVY Adoption Headlines? [Yahoo! Finance]
Medium
Report
Has The Market Rerated Tarsus Pharmaceuticals (TARS) Too Cautiously After XDEMVY Adoption Headlines? [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
2/23/2026
04:05 pm
tars
tarsus pharmaceuticals, inc.
MISS
Report
7.8%
tarsus pharmaceuticals, inc.
11/4/2025
04:05 pm
tars
tarsus pharmaceuticals, inc.
BEAT
Report
-4.6%
tarsus pharmaceuticals, inc.
8/6/2025
04:05 pm
tars
tarsus pharmaceuticals, inc.
MISS
Report
15.2%
tarsus pharmaceuticals, inc.
5/1/2025
04:05 pm
tars
tarsus pharmaceuticals, inc.
BEAT
Report
-5.3%
tarsus pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/19
07:05 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Whitfield Dianne C.
Neutral
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Whitfield Dianne C.
3/19
07:05 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Wahl Bryan
Neutral
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Wahl Bryan
3/19
07:04 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Mottiwala Aziz
Neutral
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Mottiwala Aziz
3/19
07:04 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Lin Elizabeth Yeu
Neutral
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Lin Elizabeth Yeu
3/19
07:04 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Azamian Bobak R.
Neutral
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Azamian Bobak R.
3/19
07:04 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Farrow Jeffrey S
Neutral
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Farrow Jeffrey S
3/19
07:04 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Neervannan Seshadri
Neutral
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Neervannan Seshadri
3/19
04:43 pm
tars
Form 144 Tarsus Pharmaceuticals, Filed by: Farrow Jeffrey S
Low
Report
Form 144 Tarsus Pharmaceuticals, Filed by: Farrow Jeffrey S
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: